Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients

dc.contributor.authorRiquelme, AJ
dc.contributor.authorCalvo, MA
dc.contributor.authorGuzman, AM
dc.contributor.authorDepix, MS
dc.contributor.authorGarcia, P
dc.contributor.authorPerez, C
dc.contributor.authorArrese, M
dc.contributor.authorLabarca, JA
dc.date.accessioned2024-01-10T12:08:21Z
dc.date.available2024-01-10T12:08:21Z
dc.date.issued2003
dc.description.abstractSaccharomyces boulardii is widely used as a probiotic compound. Clinical data suggest that this agent is safe and effective. We report two cases of fungemia caused by S. cerevisiae occurring in immunosuppressed patients treated orally with S. boulardii. Molecular typing confirmed clonality in isolate strains from patients and the S. boulardii capsule. Physicians caring for immunosuppressed patients must be aware of this potential serious complication of probiotic use.
dc.fechaingreso.objetodigital2024-04-30
dc.format.extent3 páginas
dc.fuente.origenWOS
dc.identifier.doi10.1097/00004836-200301000-00013
dc.identifier.eissn1539-2031
dc.identifier.issn0192-0790
dc.identifier.pubmedidMEDLINE:12488707
dc.identifier.urihttps://doi.org/10.1097/00004836-200301000-00013
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/76383
dc.identifier.wosidWOS:000180031600013
dc.information.autorucMedicina;Arrese M;S/I;76095
dc.information.autorucMedicina;Riquelme A;S/I;3538
dc.issue.numero1
dc.language.isoen
dc.nota.accesocontenido parcial
dc.pagina.final43
dc.pagina.inicio41
dc.publisherLIPPINCOTT WILLIAMS & WILKINS
dc.revistaJOURNAL OF CLINICAL GASTROENTEROLOGY
dc.rightsacceso restringido
dc.subjectSaccharomyces cerevisiae fungemia
dc.subjectSaccharomyces boulardii
dc.subjectimmunocompromised patients
dc.subjectANTIBIOTIC-ASSOCIATED DIARRHEA
dc.subjectIDENTIFICATION
dc.subjectPREVENTION
dc.subjectCHILDREN
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleSaccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients
dc.typeartículo
dc.volumen36
sipa.codpersvinculados76095
sipa.codpersvinculados3538
sipa.indexWOS
sipa.trazabilidadCarga SIPA;09-01-2024
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients.pdf
Size:
2.37 KB
Format:
Adobe Portable Document Format
Description: